1992
DOI: 10.1021/bi00151a006
|View full text |Cite
|
Sign up to set email alerts
|

Differences and similarities in the repair of two benzo[a]pyrenediol epoxide isomer-induced DNA adducts by uvrA, uvrB, and uvrC gene products

Abstract: We have determined the role of the uvrA, uvrB, and uvrC genes in Escherichia coli cells in repairing DNA damage induced by three benzo[a]pyrene diol epoxide isomers. Using the phi X174 RF DNA-E. coli transfection system, we have found that BPDE-I or BPDE-II modified phi X174 RF DNA has much lower transfectivity in uvrA, uvrB, and uvrC mutant cells compared to wild type cells. In contrast, BPDE-III modification of phi X174 RF DNA causes much less difference in transfectivity between wild type and uvr- mutant ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
57
0

Year Published

1997
1997
2006
2006

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(65 citation statements)
references
References 17 publications
8
57
0
Order By: Relevance
“…Using a viral E. coli transfection system we have found that only uvrC mutant cells show low transfectivity for viral DNA containing N-(guanosin-8-yl)-2-aminofluorene adducts; uvrA and uvrB cells show the same transfectivity as do wild-type cells. In contrast, these three mutant cells have the same low transfectivity for UV-irradiated or N-acetoxy-2-acetylaminofluorene and anti-and syn-benzo(a)pyrene diol epoxide-modified viral DNA (20,35). These results indicate that uvrC gene products may function in a manner more complicated than simply participating in the incision step and may interact with proteins other than UvrA and UvrB in vivo.…”
Section: Discussionmentioning
confidence: 89%
“…Using a viral E. coli transfection system we have found that only uvrC mutant cells show low transfectivity for viral DNA containing N-(guanosin-8-yl)-2-aminofluorene adducts; uvrA and uvrB cells show the same transfectivity as do wild-type cells. In contrast, these three mutant cells have the same low transfectivity for UV-irradiated or N-acetoxy-2-acetylaminofluorene and anti-and syn-benzo(a)pyrene diol epoxide-modified viral DNA (20,35). These results indicate that uvrC gene products may function in a manner more complicated than simply participating in the incision step and may interact with proteins other than UvrA and UvrB in vivo.…”
Section: Discussionmentioning
confidence: 89%
“…Racemic BPDE was purchased from the NCI repository (Midwest Research Institute, Kansas City, MO). Modification of DNA with BPDE was done according to published procedures (30,31), which include repeated extractions of adducted DNA with organic solvents (water-saturated diethyl ether and isoamyl alcohol). Control DNA samples were treated with solvent (95% ethanol) only.…”
Section: Methodsmentioning
confidence: 99%
“…Purified genomic DNA was modified with BPDE and then reacted with UvrABC nucleases. UvrABC makes a dual incision seven nucleotides 5Šˆ and four nucleotides 3Šˆ to a BPDE adduct (30). The 3Šˆ incisions can be precisely mapped by amplifying the resulting 5-phosphate-containing DNA using LMPCR with P53-specific primers (6,8,35).…”
Section: Cpg Methylationmentioning
confidence: 99%
“…Results obtained in a number of animal model systems have strongly suggested that BPDE induced DNA damage initiates carcionogenesis (for review, see Harvey, 1991;Harvey, 1981;Weinstein, 1981;Pelkonen and Nebert, 1982;Beland and Poirier, 1989). The binding BPDE to DNA is greatly a ected by DNA sequence context and nucleosome structure (Kaneko and Cerutti, 1982;Boles and Hogan, 1984;Osborne, 1990;Tang et al, 1992;Smith and MacLeod, 1993;Thrall et al, 1994). Recently, using UvrABC incision and LMPCR methods to map BPDE-DNA adduct distribution in the human p53 gene in cultered HeLa cells, normal human Ā®broblasts and bronchial epithelial cells, we have found that BPDE-guanine adducts form preferentially at codons 157, 248 and 273 (Denissenko et al, 1996); these preferential binding sites correspond exactly to the major mutational hotspot sites found in smoking-associated human lung cancers (Greenblatt et al, 1994;Hollstein et al, 1996).…”
Section: Introductionmentioning
confidence: 99%